AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

How to start manufacturing unit of Bulk Drugs/API

 

Figure 1: Main process flows in API synthesis

For starting manufacturing unit of Active Pharmaceutical Ingredients, you need to compile with the specifications of Drug and Cosmetic Act & Rules. Specific requirements of premises, plant and materials for manufacture of active pharmaceutial ingredients (bulk drugs) is covered under Part 1F of Schedule M and WHO good manufacturing practice specifications. Download: Drug and Cosmetic Act, 1940 and rules, 1945 as amended upto 31st December 2016 for referring Schedule M part 1.

Bulk drug / API is the biologically active ingredient in a pharmaceutical drug. It is used in a finished pharmaceutical product (FPP), intended to be used for pharmacological activity.

Bulk Drug manufacturing license is issued by state drug control office and file has to be submitted for grant of manufacturing license of bulk drugs/active pharmaceutical ingredients.

Licenses and NOC Required:

Requirements:

  • Premises
  • Machinery and equipment
  • Technical Persons
  • Staff etc

Machinery and Equipments:

  • SS and Glass Lined reactors having capacity 160 Ltr to 5000 Ltr
  • SS and MS Rubber Lined Centrifuges
  • Glass Assemblies
  • Tray dryer
  • Filters
  • Air Jet Mill
  • Sifter
  • Blender
  • Multi Mill
  • Packing area etc.

Laboratory Equipments:

  • TOC Analyzer
  • Gas Liquid Chromatograph
  • Total Organic Carbon analyzer
  • Ultra Pure Water purification system
  • Video Microscope
  • Fourier Transform Infra Red Spectrophotometer
  • Automatic Glass Ware Washing and Drying Machine
  • High Performance Liquid Chromatographs etc.

Qualification required for technical person for manufacturing:

  • A graduate in Pharmacy or Pharmaceutical Chemistry of 1[a University established in India by law or has an equivalent qualification recognized and notified by the Central Government for such purpose] and has had at least eighteen months‘ practical experience after the graduation in the manufacture of drugs to which this licence applies; this period of experience may however be reduced by six months if the person has undergone training in manufacture of drugs to which the licence applies for a period of six months during his University course; or
  • A graduate in Science of 1[a University established in India by law or has an equivalent qualification recognized and notified by the Central Government for such purpose] who for the purpose of his degree has studied Chemistry 3[or Microbiology] as a principal subject and has had at least three years‘ practical experience in the manufacture of drugs to which this licence applies after his graduation; or
  • A graduate in Medicine of 1[a University established in India by law or has an equivalent qualification recognized and notified by the Central Government for such purpose] with at least three years‘ experience in the manufacture and pharmacological testing of biological products after his graduation; or
  • A graduate in Chemical Engineering of a University recognised by the Central Government with at least three years‘ practical experience in the manufacture of drugs to which this licence applies after his graduation; or
  • Holding any foreign qualification the quality and content of training of which are comparable with those prescribed in clause (a), clause (b), clause (c) or clause (d) and is permitted to work as competent technical staff under this Rule by the Central Government.

Qualification of technical person for laboratory:

A degree in Medicine or Science or Pharmacy or Pharmaceutical Chemistry of a University recognized for this purpose and shall have experience in the testing of drugs, which in the opinion of the Licensing authority is considered adequate.

List of Documents to be submitted for grant of manufacturing license of Bulk Drugs:

  • Introductory Covering Letter mentioning Name and address of plant and administration office
  • Application at prescribed Form and format
  • Prescribed Fee Receipt
  • Details of constitution of firm, partnership or Company
  • Documents related to Ownership of premises or Rent or Lease documents
  • Identity Proof of all Authorized persons, proprietor, partners and/or directors
  • Details of Technical Staff e.g. Manufacturing Chemist and Analytical Chemist with education documents and approval certificates which is applicable
  • List of machineries and laboratory equipments
  • Site Mater File
  • Blue print of Plant and layout of premises specifying installation of machinery and equipments
  • Design and Layout of HVAC system
  • List of bulk drugs to be manufactured in manufacturing unit
  • Water analysis report
  • NOC if required from other departments like health department, pollution department or fire deparment etc.
  • Factory Act Registration if applicable

 

Plant Lay Out Requirements in API Industry: GMP Perspective

INTRODUCTION

As the API manufacturing industry is rapidly growing in India, many manufacturing units are coming up in various locations. The export market potential for APIs is also growing at a rapid pace due to generic regime. Generic drugs are less expensive as generic manufacturers do not have the investment costs of the developer of a new drug.

Usually, new drugs are developed under patent protection. The patent protects the investment – including research & development, marketing, and promotion — by giving the company the sole right to sell the drug while it is in effect. When patents expire, manufacturers can sell generic versions.

As generic drug manufacturers do not have the same development costs like the inventor, they can sell their products at substantial discounts. However, generic drug manufacturers’ facilities must meet the same standards of good manufacturing practices like brand-name firms (the inventors). Besides, regulatory authorities such as the FDA will not permit drugs to be made in sub-standard facilities.

This means generic firms should have facilities comparable to those of brand-name firms. Therefore, to tap the growing export markets, Indian generic API manufacturing units need to satisfy regulatory requirements.

To meet the regulatory requirements like US-FDA, TGA, PMDA, MHRA, GMP-WHO etc., the units need to be constructed or modified using a good and efficient plant lay out.

Need for new plant layout

A good and efficient plant layout, in short, is the disposition of the various facilities and services of the plant within the area of the site that is selected previously. Plant layout thus involves determination of space requirement for the facilities and arranging them in a manner that ensures steady flow of production with minimum overall cost.

The new plant layout requirements may arise not only to meet regulatory requirements to enter global markets, but also due to the following reasons:

•      Decision to build a new plant or plants to meet additional demand for existing product(s);

•      Introduction of new product(s) to enhance the product portfolio, or to increase revenue of the company;

•      Withdrawal of obsolete facilities;

•      Changes in product design/process design;

•      Adoption of new safety standards to meet national and/or international requirements; and

•      Re-layout of facilities to overcome the deficiencies of the existing lay- out to meet the changes.

ICH Q7 guidelines

As per the ICH Q7 guidelines, the other control systems for the following activities:

•      Receipt, identification, sampling and quarantine of incoming materials, pending release or rejection;

•      Quarantine before release or rejection of intermediates and APIs;

•      Sampling of intermediates and APIs;

•      Holding rejected materials before further disposition (e.g., return, reprocessing or destruction);

•      Storage of released materials;

•      Production operations;

•      Packaging and labeling operations; and

•      Laboratory operations.

Adequate and clean washing and toilet facilities should be provided for personnel. These facilities should be equipped with hot and cold water, as appropriate, soap or detergent, air dryers, or single service towels. The washing and toilet facilities should be separate from, but easily accessible to, manufacturing areas. Adequate facilities for showering and/or changing clothes should be provided, when appropriate.

Laboratory areas/operations should normally be separated from production areas. Some laboratory areas, in particular those used for in-process controls, can be located in production areas, provided the operations of the production process do not adversely affect the accuracy of the laboratory measurements, and the laboratory and its operations do not adversely affect the production process, intermediate, or API.

Advantages of a good and efficient plant lay out

The organization having a good and efficient plant layout has the following advantages:

•      Efficient utilization of available space;

•      Easy supervision and better production control;

•      Economy in handling of materials, work-in-process and finished goods;

•      Minimization of production delays;

•      Lesser work-in-progress and minimum manufacturing cycle time;

•      Greater flexibility for changes in product design and for future expansion; and

•      Better working conditions by eliminating causes of excessive noise, objectionable odour, smoke etc.,

Designing criteria for a good and efficient plant lay out

It is not possible to define a good plant layout in few words and no plant layout can satisfy each and every principle of a good layout. But designing criteria described below may be useful as a guidance tool to prepare a good and efficient plant lay out.

However, some criterion may conflict with some other criterion and as a result no layout can be ideal. It has to integrate all factors into the best possible compromise.

Overall integration of factors

A good plant layout is one  that buildings and facilities design and construction (refer to Clause 4.1) should be as follows.

Buildings and facilities used in the manufacture of intermediates and APIs should be located, designed, and constructed to facilitate cleaning, maintenance, and operations as appropriate to the type and stage of manufacture.

Facilities should also be designed to minimize potential contamination. Where microbiological specifications have been established for the intermediate or API, facilities should also be designed to limit exposure to objectionable microbiological contaminants, as appropriate.

Buildings and facilities should have adequate space for the orderly placement of equipment and materials to prevent mix-ups and contamination.

Where the equipment itself (e.g., closed or contained systems) provides adequate protection of the material, such equipment can be located out- doors.

The flow of materials and personnel through the building or facilities should be designed to prevent mix-ups or contamination.

There should be defined areas  or integrates 3M (i.e., men, materials, machines) and supporting activities and others in a way that the best compromise is obtained.

Minimum movement

A good plant layout is one that permits the minimum movement between the operations.

•      The plant and machinery, in case of product layout, and departments, in case of process layout, should be arranged as per sequence of operations of most of the products;

•      Since straight line is the shortest distance between any two points, men and materials, as far as possible, should be made to move along the straight path; and

•      A door may be made in a wall or a hole may be drilled in a ceiling if that eliminates or reduces material handling in place of stairs or a distant door.

Unidirectional flow

A good layout is one that makes the materials move only in the forward direction, towards stage of completion, without any backtracking. This helps in preventing cross-contamination and mix-ups.

Since straight line is the shortest distance between any two points, materials as far as possible should be made to move on the principle of straight line flow. And when straight line flow is not possible (for example, in case of old manufacturing units or where the space is constraint), other flows like U-shaped flow,   circular flow or zig-zag flow may be adopted, but the layout must ensure that materials move in the forward direction.

•      To ensure forward flow, equipment, if necessary, may have to be duplicated.

Effective use of available space

A good layout is one that makes effective use of available space, both horizontal and vertical.

•      Back-tracking and duplicated movements consume more time, involving unnecessary materials handling. This adds to cost and leads to inefficiency.

•      Raw materials, work-in-progress and finished goods should be piled vertically one above another, rather than being strewn (scattering here & there without order) on the floor.

•      Pallets or equivalents should be made use of to pile up several layers one above another, wherever possible and acceptable as per relevant guidelines.

•      Areas below the work tables or in cupboards built into the wall are welcome since they reduce requirement of space.

Maximum visibility

A good plant layout is one that makes men, machines and materials readily observable at all times. To achieve this objective the following points to be taken care of:

•      All departments should be smoothly integrated, convenient to service and easy to supervise;

•      Every piece of positioning or screening or partitioning should be scrutinized and carefully planned; and

•      Special cupboards, enclosures, partitions etc. should be avoided, except when their utility is established beyond doubt.

Maximum accessibility

A good plant layout is one that makes all servicing and maintenance points readily accessible. This objective can be achieved by:

•      Keeping machines/equipment sufficiently apart and with reasonable clearance from the wall, so that lubrication, adjustment and replacement of belts, removal of parts at the time of repairs etc. can be done conveniently by the maintenance department personnel; and

•      Keeping area in front of electrical panels and fire extinguishers free from obstructions.

Minimum handling

A good layout is one that reduces the materials handling activity to its minimum.

•      Material should be stored as close to the point of use as possible;

•      Materials being worked upon should be kept at working height and should never be placed on floor to avoid lifting;

•      Materials should not be handled twice in the same direction; and

•      Materials should be handled in as big and convenient lots as possible.

Inherent safety

A good plant layout is one that makes the plant safer for the work- men.

•      The aisles (gangways, narrow pas- sages) should be clearly marked and should be kept free from obstructions.

•      The aisles should be located in such a way that workmen do not have to walk close to storage tanks (overhead tanks or day tanks or addition tanks), thermic fluid boilers etc.

•      ‘Pick up’ and ‘put down’ points for materials should be so located that material handling facility – material lifting hoists – do not endanger safety of machines or workmen.

•      Fire protection equipment should be provided at strategic locations. Fire hydrant system with required points at strategic locations is preferred in API manufacturing units as solvents handling is more in these companies.

•      Gangways should be kept well lit.

•      One way traffic rule should be observed in areas of greater traffic.

Safe and improved environments

A good plant layout is one that makes the work centers and the area around them satisfying to working personnel.

•      The work place should be free from disagreeable elements like heat, smoke, dust, obnoxious fumes etc.

•      The selection of the colors for the walls in the working areas (Production blocks, QC, QA, E&M, R&D, workshop, office, etc.) should be such that they are soothing to the eyes. Use of bright colors should be avoided in all the places of plant.

•      Height of work place should  be kept high enough to avoid the need to bend while working.

•      A stool or a chair may be provided, wherever necessary, to enable alternate standing and sitting.

Maximum flexibility

A good plant layout is one that can be altered later without much cost.

•      Future requirements should be taken into account while designing for the present. Space requirements for different departments, direction of expansion etc. should be planned in such a way that changes can be made without any disruption of plant operations.

•      Each machine must be self-contained, i.e. constituting a complete and independent unit in and of itself or it must have everything of its own like steam provision, cooling system, lighting, air system etc.

•      Multipurpose machines or equipment give flexibility over special purpose machines or equipment and process layout is more flexible than product layout. Try to keep multipurpose equipment, which give flexibility over special purpose/ single product use equipment.

•      Standardization of machine tools, jigs and fixtures, give flexibility to production in the event of machine breakdown.

Maximum security

A good plant layout is one that safe- guards the plant and machinery against fire, theft etc. without employing too many cages, doors and barriers. Since a layout once made can be changed/modified only at considerable cost, disrupting production operations, plant layout decisions are strategic decisions. A good layout results in comforts, convenience, appearance, safety, efficiency and profits, while a poor layout causes congestion, disruption in material flow, unnecessary material handling, more scrap and rework/reprocess, higher throughput time, wasted movements, frustration and inefficiency.

Generally, the waste (losses) resulting from unnecessary handling and wasted movements as a consequence of inefficient layout is not immediately realized, as most of these elements do not appear in the financial statements of the company.

Management generally fails to recognize the extent of money going down the drain because of poor layout. The importance of a well-designed plant layout, therefore, is second to none.

Glossary

Plant layout: Plant layout is the plan of or the act of planning an optimum arrangement of facilities, including personnel, operating equipment, storage space, materials handling equipment and all other supporting services along with the design of the best structure to contain these facilities.

Plant layout is the placing of right equipment coupled with right method in the right place to permit the processing of a product in the most effective manner through the shortest possible distance and through the shortest possible time.

Process or functional lay out : Process layout, also called ‘layout by function,’ is generally associated with batch production where the factory is divided into process units (or departments) and within these process units (or departments) all similar facilities are grouped together.

Project or fixed position lay out: Heavy materials, components or sub-assemblies, under this, layout remains fixed at one place. Men, machines and tools are brought to the location to complete the job.

Generic drug: A generic drug is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use.

Design of a New Facility
The cGMP regulations, as they are written, apply to the manufacture of drugs in their final dose form, but the FDA applies the regulations to the manufacture of bulk APIs. In addition, they also apply these regulations to the manufacture of drug intermediates if the manufacture of an intermediate is a “critical” step. They define a critical step as one that affects part of the drug’s Characterization , such as its crystalline form or impurity profile.

Much of the cGMP regulations address architectural or civil engineering issues such as requirements for adequate lighting and waste water drainage. Lights and electrical fixtures must be cleanable, or else placed in recessed enclosures. All incoming raw materials must be approved and labeled by quality control ( QC ), which requires sufficient warehouse space to separate pre-approved raw materials (quarantined) from approved raw materials. Additional floor space is also required to allow segregation of quarantined and approved products and intermediates.

The FDA is flexible with its requirements for the protection of product from contamination, allowing different levels of protection based on the level of product exposure and whether the exposure occurs at a pre-critical or a critical stage of manufacture. For example, if an existing chemical plant is being converted to manufacture APIs, temporary plastic curtains can be placed around reactors to provide isolation during times when the reactor is open (such as during the charging of solids through the manway or transfer of solids from the centrifuge to the dryer). However, in our case, we were building a new facility rather than attempting to convert an existing one. We chose to design the highest non-aseptic level of protection available and chose the suite design to maximize control and isolation of the product.

Only one product is typically made in a suite at one time. Equipment rooms separate the suites (see Figure 1, p. 34 in printed version). All utilities, support equipment and electrical boxes are isolated in the equipment rooms, as much as smooth operation will permit; all wall penetrations are sealed. Filters are located on both vacuum and nitrogen lines. Each suite has a separate gowning room and materials staging room. Clean-room walls (which are epoxy Coated ), ceiling and floor allow vigorous cleaning with direct spray from a water hose. There is no piping or equipment above the reactor manways or dryer manway to accumulate dust and potentially contaminate the product.

A dedicated HVAC system supplies air to each suite and provides a positive pressure to the suite to minimize outside contamination. The HVAC recycles air with either 95% or high efficiency particulate air ( HEPA ) filtration, depending on production requirements. Because recirculation of flammable vapors could potentially create a dangerous situation, lower explosive limit (LEL) sensors are located in the HVAC return air ducts. The air handler controller will automatically switch to full exhaust if flammable vapors are detected at a concentration of 25% or more of LEL.

Although the first suite is under a positive pressure to the rest of the building, the second suite can be under either a positive or a negative pressure. A negative pressure is desirable when compounds such as radioisotopes or Cytotoxic drugs are being manufactured.

USP -grade water runs in a continuous loop from the holding tank, throughout the plant, and back to the holding tank. The recirculation pipe has “drops” at each point of use, but no deadlegs (dead-end pipes at least five pipe diameters long). The water entering the loop is treated with UV sterilization and 0.2µ filtration to remove bacterial contamination. This meets the requirement that water does not introduce contaminants into the product.


Commissioning
As construction comes to a close, commissioning begins. Commissioning is the step in which equipment is prepared for startup. Installed piping and equipment is compared to the piping and instrumentation diagram (P&ID), utility connections are confirmed, as-built drawings are prepared, equipment is started to confirm power and motor rotation, instruments are calibrated and control loops are tuned. This is a traditional engineering activity, and it is also a cGMP requirement. However, for a pharmaceutical facility, it is called equipment qualification and the documentation requirements are more extensive than they are for traditional commissioning. As with commissioning, equipment qualification is typically performed by the engineering department with assistance from manufacturing and QA departments.

Qualification is the documented action of showing that installed equipment provides consistent control of critical parameters in critical processes. It is the first step of Validation , which is the process of documenting that a process or system will consistently produce the desired results. As the saying goes, “Quality can’t be tested into a product; it must be built into the product.”

Qualification documentation is formalized so that an outside auditor (who may not be an engineer or chemist) can confirm what was done. This documentation includes a page for recording data on any test instruments used in the qualification and a page to record any deviations from the established Protocol . The deviations page requires the endorsement of the QA department. A typical size for a qualification document is 15 to 30 pages, not counting vendor specification sheets, O&M manuals and engineering drawings.

A list of critical equipment and systems at our facility that required qualification is given in Table 1 (left). Non-critical items are still commissioned, but do not require qualification. Non-critical systems are those that do not contact the product, including the fire protection and security systems, breathable air systems, cranes and hoists. It should be noted that the QC laboratory also has to perform similar qualification of their equipment.

Equipment qualification can be broken down into Installation Qualification ( IQ ) and Operational Qualification ( OQ ). For the most part, IQ is performed before the power is turned on, while OQ is the actual operating of the equipment. To simplify documentation, IQ and OQ may be combined into a single equipment qualification, but we chose to leave them as separate documents and will address them as such here.
After IQs and OQs are completed, a final report is written confirming that the required steps were completed. Engineering, manufacturing and QA signatures are required on this report.

Installation Qualification
A sample page from the IQ of one of our reactors is shown in Figure 2 (p 38 in printed version). The IQ includes pages that:

• Record all nameplate data: document sizes and model numbers of pumps, heat exchangers, valves, and filters.

• Verify that equipment was installed as specified.

• List all materials of construction that will be in contact with the product.

• Identify lubricants: lubricants in the reactor agitator’s shaft seal must be food grade or FDA-approved. We used a mineral oil shaft seal and applied an FDA-approved grease to dump valve threads. These restrictions did not apply to equipment that was not in product contact, such as the circulating pump for the reactors’ jacket oil or the bearings on the HVAC fan motor (however, this restriction would apply if the fan’s bearings and motor were in the air stream).

• Verify that proper utilities have been installed, including the voltage on all three legs of three-phase power brought to the equipment, as well as the instrument air, hot oil and chilled water.

• Verify that piping is leak free before it is insulated. Verify the slope of any drain piping. Note: the best time to perform this step is during the construction phase.
• Identify the critical parameters of the reactions to be carried out. Instruments used to measure those parameters will be identified as critical instruments and will require enhanced documentation. For example, the reactor temperature is critical to the product, but not the jacket temperature (although jacket temperature controls reactor temperature). Also, reactor pressure is not critical when gas phase reactants are not present, so pressure gauges are not defined as critical instruments. Pressure in a vacuum dryer may be critical, however, and must be validated and regularly calibrated. Document your rationale in the IQ for identifying instruments as non-critical.

• Document the preparation of as-built drawings (P&ID and general arrangement, for example).

• Obtain all operation and maintenance documents from equipment vendors. Prepare a list of maintenance procedures.

• Document passivation of stainless steel condensers.

• Document the known history of used equipment. This makes the next step (cleaning validation) easier since it lets the QC department know what potential residues may be present.

• Document cleaning and testing of the reactor to confirm removal of residues. Testing includes GC or HPLC analysis of final rinse samples (both water and methanol) and TOC analysis of swab samples. For us, the greatest difficulty of this step was finding swabs that did not contribute TOC to the sample.

Operational Qualification
As stated before, the IQ can be mostly performed without turning on the equipment. It is during the OQ that the engineer confirms that equipment operates as expected. Writing the protocol for the OQ requires set acceptance criteria for each test. For instance, if a certain vacuum is required in the vacuum dryer, the tester must document that the required vacuum was obtained.

For a Batch facility like ours, where the same reactors, centrifuges and dryers are used to make many different products, it was important to write the protocol for the equipment OQ to cover all anticipated process or product applications. Otherwise, the OQ would have to be repeated for new products. It is also important to operate the equipment over the range that it might be reasonably expected to cover.

The OQ includes pages to:

• Calibrate critical instruments and determine the frequency of future calibrations. Critical instruments must be calibrated against another instrument that is used as the plant standard. The plant standards must periodically be sent outside for calibration against a NIST standard. Traceable standards are an important feature of any quality program and their use, availability and certificate of analysis or calibration should be included in the documentation.

• Test and document each control valve, switch, recorder and every other hardware control element.

• Test and document that reactors, centrifuges and dryers can be inerted and vented and can be pressurized with nitrogen.

• Test pressure vessels under vacuum and pressure.

• Test and document manual and automatic operation of the equipment. In the case of the reactors and dryers, we filled them with water and tested the ability to heat and cool and to hold a set point. This step should be done at the minimum and maximum liquid level expected in the equipment and over the range of temperatures expected.

• Record the amperage draws of equipment during the operation and compare them to the nameplate data.

• Configure controllers and tune control loops. Document all settings.

• Test operation of the HVAC. Positive suite pressure was documented in both recirculation and exhaust mode. We documented proper operation of the temperature control and the alarms (LEL, freeze protection, fire protection).

• List Standard Operating Procedures (SOPs) associated with new equipment. Since some critical parameters are controlled (or at least affected) manually, SOPs and operator training are like critical instruments. Engineering worked with manufacturing to prepare SOPs and provide documented and verified training.

• Write Maintenance Procedures and deliver to the maintenance department. Make these realistic and specific. O&M manuals frequently had generic lists of maintenance procedures with many procedures that did not apply to the models we purchased.
Qualification of the nitrogen system required enhanced documentation, since nitrogen contacts the product. Raw material testing is required on each delivery before it is pumped into the liquid nitrogen tank, so a testing procedure was written. This added precaution comes at a premium, since it requires that our nitrogen supplier coordinate delivery with the QC Unit.

Change Control
After QA signed the qualification documents, they became controlled documents. This means that a change control form must be prepared and approved through QA to make any changes to the equipment. Such changes might include adding additional drops to the USP water loop, extending the utilities to a new reactor or reprogramming the controllers.

Change control can be constricting. It requires the engineer to obtain prior permission before altering or optimizing plant equipment. This tends to lock in practices and creates a barrier to change. However, it is designed to prevent one individual or department from making changes without notifying other departments. As a communication tool, the change control procedure prevents optimizing a single function at the expense of the overall facility.

Performance Qualification
Most of the equipment is declared ready for use after the OQ. However, the USP water system required a Performance Qualification ( PQ ) after the OQ was completed. The PQ applies more to a process or a system than to a piece of equipment; it confirms that the system produces a consistent product, day after day.

A PQ of the other utilities was not performed because, with the exception of nitrogen, they do not contact the product. Qualification of nitrogen was handled as described above. Although the hot oil and chilled water systems are used to control reactor temperature, which is a critical parameter, neither of these systems requires validation beyond routine equipment qualification.

Whereas engineering had performed most of the IQs and OQs, QA took over for the USP water PQ. The USP water system had to be proven to meet USP standards consistently, including standards for conductivity, TOC and microbial load. This required daily samples from each sample point for one month, which was long enough to encompass several idle periods (such as weekends) and loop sanitizations. In addition to collecting samples for analysis by a local water quality lab, resistivity is measured on-line and recorded weekly and whenever a sample is collected.

Microbial load is controlled by periodic sanitization of the entire USP water system. We adapted a procedure from one of our clients, a large pharmaceutical manufacturer, in which enough bleach is added to the system to bring the chlorine residual to 60-75 mg/L. This chlorinated water is circulated throughout the system for at least two hours and then discharged. The system is then flushed and refilled.

Problems were initially encountered with TOC measurements. This turned out to be the result of using alcohol to sanitize the sample points. After the disinfectant was switched to bleach, followed by more thorough flushing, the USP water system was able to meet TOC limits.

Guidelines for Streamlining Qualification
In our case, the same people who prepared the qualification protocols completed the qualification packages and wrote the final reports. This gave us a perspective on the process from start to finish that has allowed us to perform the qualification process efficiently. We offer the following tips.

• Write the Qualification protocols using standard templates. These templates should be prepared by the engineering department, since they are most familiar with the equipment. Make the protocol specific to the equipment. A template that is too generic will increase time and paperwork needlessly.

• Make sure that acceptance criteria are reasonable. The acceptance criteria should be set somewhere between what the vendor claims and what the process requires.

• Prevent duplication. Make installation, start-up testing and any installation performed by the vendor part of the IQ and OQ, rather than repeating these tests. Making pages from the IQ and OQ documents part of the vendors’ turnover package is a simple way to accomplish this goal. In addition, the construction manager will be confirming leak testing and drainage testing on piping anyway, so have him/her complete these portions of the IQ.

• Revalidation after changes (made through proper change control procedures, of course) usually does not need to be as in-depth (and expensive) as the original qualification. For instance, after extending the USP water loop piping and adding new drops, only limited water testing was required to confirm that cleaning and sanitization were effective.

Successfully commissioning the new facility to cGMP standards has let Pisgah Labs enter the contract manufacturing market for APIs. Our facility began production of a commercial Drug Product soon after commissioning. Our client performed an Audit before manufacturing that found no room to comment on the manufacturing facilities or the qualification of equipment. After we began manufacturing, the FDA’s Pre-Approval Inspection ( PAI ) did not produce any deficiencies related to facilities or equipment. For Pisgah Labs, this served as a confirmation of our ability to design, commission and operate a cGMP bulk pharmaceutical manufacturing plant. n

References
Guides For New Facilities, Volume 1, Bulk Pharmaceutical Chemicals, First Edition, International Society of Pharmaceutical Engineering. June 1996

Streamlining Validation, by the ISPE San Francisco/Bay Area Chapter, in Pharmaceutical Engineering. January/February 1998, pp. 8-24.

7,443 total views, 1 views today

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: